T-cell receptor specific for influenza A(H1N1)pdm09 peptides (TCR (pdm09-specific))

The T-cell receptor (TCR) specific for influenza A(H1N1)pdm09-derived peptides is a specialized protein complex found on the surface of CD4+ T helper cells that mediates the adaptive immune response to the 2009 pandemic H1N1 virus. These TCRs recognize specific viral epitopes, such as those from the hemagglutinin (HA) or matrix proteins, only when they are processed and presented by Major Histocompatibility Complex (MHC) class II molecules on the surface of professional antigen-presenting cells [1][2]. This interaction is a critical checkpoint in the immune system, triggering T-cell differentiation into various effector subsets that support B-cell antibody production and coordinate the overall antiviral response [3]. In clinical contexts, these TCRs are the primary targets of influenza vaccines, which aim to expand the population of memory T cells bearing these receptors to provide rapid protection upon infection [4]. Furthermore, research into the structural basis of this recognition has led to the development of TCR-engineered T-cell therapies and universal vaccine strategies designed to target conserved epitopes across different influenza strains [5].

Other names

Influenza A(H1N1)pdm09-specific TCRCD4+ T-cell receptor for pandemic H1N1pdm09-specific T-cell receptorH1N1pdm09-specific CD4+ TCR

Recognition of peptide-MHC class II complexes leading to intracellular signaling via the CD3 complex and subsequent T-cell activation.